Trial Profile
A randomized, placebo-controlled phase I trial of recilisib (EX-RAD, ON 01210.Na) in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Apr 2015
Price :
$35
*
At a glance
- Drugs Recilisib (Primary)
- Indications Acute radiation syndrome
- Focus Adverse reactions
- 13 Apr 2015 New trial record